Evidence map›Paper›PMID 31663508›Full record

ArticleeLife2019

Transient protein accumulation at the center of the T cell antigen-presenting cell interface drives efficient IL-2 secretion.

Danielle J Clark, Laura E McMillan, Sin Lih Tan, Gaia Bellomo, Clementine Massoue, Harry Thompson, Lidiya Mykhaylechko, Dominic Alibhai, Xiongtao Ruan, Kentner L Singleton and 6 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Danielle J Clark *School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Laura E McMillan *School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Sin Lih TanSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Gaia BellomoSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Clementine MassoueSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Harry ThompsonSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Lidiya MykhaylechkoSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Dominic AlibhaiSchool of Biochemistry, University of Bristol, Bristol, United Kingdom.
Xiongtao RuanComputational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, United States.
Kentner L SingletonDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
Minna DuDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
Alan HedgesSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Pamela L SchwartzbergGenetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, United States.
Paul VerkadeSchool of Biochemistry, University of Bristol, Bristol, United Kingdom.
Robert F MurphyComputational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, United States.ORCID https://orcid.org/0000-0003-0358-901X
Christoph WülfingSchool of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.ORCID https://orcid.org/0000-0002-6156-9861
University of Bristol · GBThe University of Texas Southwestern Medical Center · USCarnegie Mellon University · USNational Institutes of Health · USUniversity of Freiburg · DE

Funding

TrainingP41GM103712 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FAEDER, JAMES · 2012 to 2021
$16.3M
Biotechnology and Biological Sciences Research Council BB/P011578/1H2020 European Research Council PCIG11-GA-2012-321554National Science Foundation MCB1121793National Science Foundation MCB1121919National Science Foundation MCB1616492NIGMS NIH HHS P41 GM103712NIH HHS P41 GM103712
6 · The paper itself

Abstract

Supramolecular signaling assemblies are of interest for their unique signaling properties. A µm scale signaling assembly, the central supramolecular signaling cluster (cSMAC), forms at the center of the interface of T cells activated by antigen-presenting cells. We have determined that it is composed of multiple complexes of a supramolecular volume of up to 0.5 µm

Indexed as

Cell CommunicationAdaptor Proteins, Signal TransducingAnimalsAntigen-Presenting CellsCD28 AntigensCells, CulturedGRB2 Adaptor ProteinInterleukin-2Membrane ProteinsMicePhosphoproteinsReceptor Protein-Tyrosine KinasesT-LymphocytesAdaptor Proteins, Signal TransducingCD28 AntigensGRB2 Adaptor ProteinGrb2 protein, mouseInterleukin-2Lat protein, mouseLtk protein, mouseMembrane ProteinsPhosphoproteinsReceptor Protein-Tyrosine KinasesSLP-76 signal Transducing adaptor proteinscell biologyimagingimmunologyinflammationmousesignal transductionsupramolecular protein complexT lymphocytes

Identifiers

PMID31663508
PMCPMC6821493
OpenAlexW2981392364

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.